1LB 5-Year Overall Survival Update from the X-ACT Trial of Capecitabine Vs. 5-FU/LV As Adjuvant Treatment for Stage-Iii Colon Cancer
European journal of cancer Supplement（2007）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined